Quantum BioPharma Ltd.
QNTM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4 | $36 | $31 | $36 |
| - Cash | $6 | $3 | $17 | $35 |
| + Debt | $1 | $0 | $1 | $1 |
| Enterprise Value | -$1 | $34 | $14 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14 | -$16 | -$22 | -$30 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$18 | -$24 | -$35 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.49 | -29.39 | -39.62 | -65.63 |
| % Growth | 57.5% | 25.8% | 39.6% | – |
| Operating Cash Flow | -$7 | -$11 | -$28 | -$21 |
| Capital Expenditures | $0 | $0 | -$0 | -$1 |
| Free Cash Flow | -$7 | -$11 | -$29 | -$21 |